Overview


Cardiac markers are analysis tools used to diagnose and identify risk in individuals with chest discomfort, acute coronary syndrome (ACS), and acute myocardial infraction (MI). Cardiac marker tests detect endogenous compounds released during blood circulation, primarily when the heart is injured or strained, allowing doctors to estimate risk and provide appropriate therapy for high-risk patients. In hospitals, cardiac markers are used to diagnose heart injury or to assess the risk of cardiovascular illness in the future. Cardiovascular markers such as myoglobin, homocysteine, troponin T (cTnT), troponin I (cTnl), creatine kinase-MB (CK-MB), and C-reactive protein (CRP) are used to diagnose acute myocardial infraction. In high-risk individuals, however, CK-MB, cTnl, and cTnT are utilised to diagnose and treat acute coronary syndrome. Due to their increased sensitivity and specificity for detection of myocardial infraction, cardiac troponin I and T are the most favoured and widely utilised cardiac markers for myocardial damage. The market for cardiac marker testing equipment is growing due to an increase in the frequency of myocardial infraction (MI) or heart attack, acute coronary syndrome, and increasing development of cardiac markers by existing industry participants. High blood pressure, high LDL cholesterol, smoking, a poor diet, diabetes, obesity, lack of physical activity, and excessive alcohol consumption are all factors that contribute to coronary heart disease and its disorders. As a result, the global cardiac marker testing devices market is predicted to rise substantially in the near future.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cardiac Marker Testing Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cardiac Marker Testing Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Bio-Rad Laboratories Inc.
  • Siemens Medical Solutions USA Inc
  • Randox Laboratories Ltd.
  • Abbott Laboratories
  • Becton Dickinson and Company
  • Helomics Corp.
  • LSI Medience Corporation.
  • F.Hoffmann-La Roche Ltd.
  • Enzo Biochem Inc
  • Ortho Clinical Diagnostics
  • Danaher Corporation
  • BioMerieux SA

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Marker Type

  • Lactate Dehydrogenase
  • Creatine Kinase (CK)
    • CK-MM
    • CK-MB
    • CK-BB
  • Myoglobin
  • Natriuretic Peptides
  • Aspartate Aminotransferase (AST)
  • Cardiac Troponin
  • C-reactive Proteins
  • Others (galectin-3, myeloperoxidase, homocysteine, H-FABP, and ischemia-modified albumin)

By Product Type

  • Instruments
    • Chemiluminescence
    • Immunofluorescence
    • Immunochromatography
    • ELISA
  • Reagents and kits

By Application

  • Acute Coronary Syndrome (ACS)
  • Myocardial Infraction (MI)
  • Cardiac Heart Failure
  • Others

By Testing Type

  • Laboratory Testing
  • Pont-of-care Testing

By End User

  • Hospitals
  • Diagnostic Laboratory
  • Home care setting

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Cardiac Marker Testing Devices Market By Marker Type, By Product Type, By Application, By Testing Type, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cardiac Marker Testing Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cardiac Marker Testing Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cardiac Marker Testing Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cardiac Marker Testing Devices Market, By Marker Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Lactate Dehydrogenase
        2. Creatine Kinase (CK)
         2.1. CK-MM
         2.2. CK-MB
         2.3. CK-BB
        3. Myoglobin
        4. Natriuretic Peptides
        5. Aspartate Aminotransferase (AST)
        6. Cardiac Troponin
        7. C-reactive Proteins
        8. Others (galectin-3, myeloperoxidase, homocysteine, H-FABP, and ischemia-modified albumin)

  • 8.   Cardiac Marker Testing Devices Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Instruments
         1.1. Chemiluminescence
         1.2. Immunofluorescence
         1.3. Immunochromatography
         1.4. ELISA
        2. Reagents and kits

  • 9.   Cardiac Marker Testing Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Acute Coronary Syndrome (ACS)
        2. Myocardial Infraction (MI)
        3. Cardiac Heart Failure
        4. Others

  • 10.   Cardiac Marker Testing Devices Market, By Testing Types Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Laboratory Testing
        2. Pont-of-care Testing

  • 11.   Cardiac Marker Testing Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic Laboratory
        3. Home care setting

  • 12.   North America Cardiac Marker Testing Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Cardiac Marker Testing Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Cardiac Marker Testing Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Cardiac Marker Testing Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Cardiac Marker Testing Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Bio-Rad Laboratories Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Siemens Medical Solutions USA Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Randox Laboratories Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Abbott Laboratories
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Becton Dickinson and Company
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Helomics Corp.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. LSI Medience Corporation.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. F.Hoffmann-La Roche Ltd.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Enzo Biochem Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Ortho Clinical Diagnostics
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Danaher Corporation
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. BioMerieux SA
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients